Aflac Incorporated (NYSE:AFL) Shares Sold by Invesco Ltd.

Invesco Ltd. cut its position in Aflac Incorporated (NYSE:AFL - Free Report) by 6.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,665,196 shares of the financial services provider's stock after selling 253,316 shares during the quarter. Invesco Ltd. owned approximately 0.66% of Aflac worth $379,128,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Aflac by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock worth $5,310,640,000 after acquiring an additional 653,275 shares during the period. Geode Capital Management LLC increased its holdings in shares of Aflac by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 12,465,433 shares of the financial services provider's stock valued at $1,286,042,000 after purchasing an additional 288,482 shares in the last quarter. Norges Bank bought a new position in shares of Aflac in the 4th quarter valued at about $349,699,000. Charles Schwab Investment Management Inc. increased its stake in shares of Aflac by 1.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider's stock valued at $333,768,000 after acquiring an additional 47,119 shares during the last quarter. Finally, Amundi increased its holdings in shares of Aflac by 81.1% in the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider's stock worth $285,181,000 after acquiring an additional 1,232,683 shares in the last quarter. Institutional investors own 67.44% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. BMO Capital Markets started coverage on Aflac in a report on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 target price on the stock. Piper Sandler raised their price objective on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. StockNews.com raised Aflac from a "sell" rating to a "hold" rating in a research report on Friday, February 14th. Finally, UBS Group upped their target price on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Aflac has a consensus rating of "Hold" and an average price target of $103.93.

Aflac Trading Up 0.1 %

Shares of AFL stock traded up $0.15 during trading hours on Tuesday, reaching $108.66. The company's stock had a trading volume of 280,124 shares, compared to its average volume of 2,138,812. Aflac Incorporated has a one year low of $79.69 and a one year high of $115.50. The stock has a market capitalization of $59.31 billion, a P/E ratio of 11.32, a P/E/G ratio of 3.24 and a beta of 0.81. The firm's fifty day simple moving average is $106.37 and its 200 day simple moving average is $107.39. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Equities research analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.

Insider Activity

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares of the company's stock, valued at $5,360,422.98. This trade represents a 37.36 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares of the company's stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company's stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.